Olopatadine Hydrochloride 16571-0882
Product NDC
16571-0882- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Solution
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- May 1, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA204392
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 1 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(1)
1 CONTAINER in 1 CARTON (16571-882-05) / 5 mL in 1 CONTAINER